Tag - takeda

 
 

TAKEDA

Japan Times
BUSINESS / Companies / FOCUS
Feb 3, 2019
Bypassing U.S. regulators, Takeda takes its dengue shot to the tropics first
A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year.
Japan Times
BUSINESS
Jan 30, 2019
Takeda dengue vaccine meets main goal of trial; detailed results to come
Takeda Pharmaceutical Co. said Tuesday that its experimental dengue vaccine appears to be safe and effective at preventing all four types of the mosquito-borne disease, meeting the main goal of the drugmaker's late-stage clinical trial.
Japan Times
BUSINESS / Companies
Jan 22, 2019
Japan drugmaker Takeda mulls sale of $3 billion in emerging-market assets
Takeda Pharmaceutical Co. is considering a sale of some emerging-market drugs as it expands a push to cut debt after buying Shire PLC for $62 billion, according to sources.
Japan Times
OLYMPICS
Jan 19, 2019
Ollan Cassell thinks embattled JOC chief Tsunekazu Takeda should step aside in wake of French probe
With serious allegations of corruption and bribery linked to Japanese Olympic Committee chief Tsunekazu Takeda, a prominent member of the global sports community issued a call for Japanese authorities to sever ties with him.
JAPAN / Crime & Legal
Jan 15, 2019
Japanese Olympic Committee head Tsunekazu Takeda denies accusation of corruption linked to 2020 bid
Takeda's denial followed reports last week that French prosecutors have brought a preliminary charge against him for alleged corruption over bidding for the 2020 Games.
Japan Times
BUSINESS / Companies
Jan 9, 2019
Takeda's CEO says it needs to sell assets quickly to cut debt
The sooner, the better.
Japan Times
BUSINESS / Companies / ANALYSIS
Dec 6, 2018
Takeda downgrade looms after shareholders approve Shire deal
Takeda Pharmaceutical Co. shareholders' approval of the $62 billion (about ¥7 trillion) acquisition of Shire PLC is good news for its bosses' ambitions to build a global drug giant — but bad news for its credit ratings.
Japan Times
BUSINESS / Companies
Nov 21, 2018
With EU approval secured, Takeda clears last regulatory hurdle for $62 billion Shire purchase
Takeda Pharmaceutical Co. has won European Union approval for its takeover of Shire PLC, clearing the last major regulatory hurdle for the $62 billion acquisition and paving the way to a shareholder vote.
Japan Times
BUSINESS / Companies
Jul 18, 2018
Takeda bets on China for global growth, seeing the country as 'on a par' with the U.S. and Europe
Takeda Pharmaceutical Co. sees China becoming a "core country" for its global growth strategy, and is optimistic its $62 billion (¥6.94 trillion) acquisition of Shire PLC will win approval by the country's regulators.

Longform

Sumadori Bar on Shibuya Ward's main Center Gai street targets young customers who prefer low-alcohol drinks or abstain altogether.
Rethinking that second drink: Japan’s Gen Z gets ‘sober curious’